Vaccines

Current Opinion in Gastroenterology

Volumn 12, Issue SUPPL. 1, 1996, Pages 41-44

  Corthésy Theulaz, Irène ^a   Ferrero, Richard L ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL TOXIN; BACTERIAL VACCINE; CHOLERA TOXIN; CYTOTOXIN; HEAT SHOCK PROTEIN; UREASE;

CLINICAL TRIAL; DRUG EFFICACY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFECTION CONTROL; NONHUMAN; SHORT SURVEY; VACCINATION; VACCINE PRODUCTION;

EID: 0029915528     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199601001-00010     Document Type: Short Survey

References (33)

1. Radcliff FJ, Chen M, Lee A: Protective immunisation against Helicobacter spp. stimulates long term immunity [Abstract]. Gut 1995, 37:A48.
2. Chen M, Lee A, Hazell S: Immunisation against gastric Helicobacter infection in a mouse Helicobacter felis model. Lancet 1992, 339:1120-1121.
3. Czinn SJ, Cai A, Nedrud JG: Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 1993, 11:637-642.
4. Doidge C, Gust I, Lee A, Buck F, Hazell S, Manne U: Therapeutic Immunisation against Helicobacter infection. Lancet 343:914-915.
5. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P: Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995, 267:1655-1658. These workers showed that it was possible to colonize mice with H. pylori. The development of a murine model of H. pylori infection is an important contribution to vaccine development because it means that H. pylori-specific antigens will be able to be tested directly in mice.
6. Buck FJ, Doidge C, Lee A: Therapeutic immunisation - The future for Helicobacter treatment [Abstract]. Gut 1995, 37:A93.
7. Michetti P, Corthésy-Theutaz I, Davin C, Haas R, Vaney AC, Heitz M, Bille J, Kraehenbuhl JP, Saraga E, Blum AL: Immunization of BALB/c mice against Helicobacter felis infection with H. pylori urease. Gastroenterology 1994, 107:1002-1011.
8. Ferrero RL, Thiberge JM, Huerre M, Labigne A: Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection. Infect Immun 1994, 62:4981-4989.
9. Corthésy-Theulaz I, Porta N, Glauser M, Saraga E, Vaney A-C, Haas R, Kraehenbuhl J-P, Blum A, Michetti P: Oral Immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology 1995, 109:115-121. In this study, mice that were already infected with H. felis were immunized with H. pylori urease B subunit, together with CT. Mice treated in this fashion were not only cleared of the infection, but also remained immune to subsequent challenges with H. felis bacteria. Therapeutic immunization was shown to be a feasible approach to the treatment of H. pylori gastritis.
10. Cuenca R, Blanchard T, Lee C, Monath T, Redline R, Nedrud J, Czinn S: Therapeutic immunization against Helicobacter mustelae infection in naturally infected ferrets [Abstract]. Gastroenterology 1995, 108:A78. These workers used a natural infection model, that of Helicobacter mustelae in ferrets, to show that therapeutic immunization could be effective in an animal species with a stomach physiology resembling that of humans.
11. Lee CK, Weltzin R, Thomas WD, Kleanthous H, Ermak TH, Soman G, Hill JE, Ackerman SK, Monath TP: Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis 1995, 172:161-172. This is a comprehensive study of the use of urease as a mucosal antigen to prevent H. felis infection in mice. Protection scores were compared with the humoral immune responses in the animals. It was shown that oral immunization was just as effective as the intragastric route in inducing protection, and also that very low doses of urease antigen were required to induce protection against H. felis infection.
12. Kleanthous H, Tibbits T, Bakios TJ, Georgopoulos K, Myers G, Ermak TH, Fox J, Monath T: In vivo selection of a highly adapted H. pylori isolate and the development of an H. pylori mouse model for studying vaccine efficacy and attenuating lesion [Abstract]. Gut 1995, 37:A94.
13. Ferrero RL, Thiberge JM, Kansau I, Wuscher N, Huerre M, Labigne A: The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci USA 1995, 92:6499-6503. This study showed that orogastric immunization with a combination of two antigens, H. pylori urease subunit B and heat shock protein A (A GroES homologue), was able to induce a level of protection against H. felis infection in mice that was statistically comparable to the induced by sonicated whole cell preparations.
14. Doré-Davin C, Michetti P, Saraga E, Blum AL, Corthésy-Theulaz I: A 37 KDa fragment of UreB is sufficient to confer protection against Helicobacter felis infection In mice [Abstract]. Gastroenterology 1996, 110:A97 This paper includes data demonstrating that a truncated form of the B subunit of H. pylori urease was able to protect mice from H. felis infection efficiently.
15. Kreiss C, Buclin T, Cosma M, Corthésy-Theulaz I, Michetti P: Safety of oral immunization with recombinant urease in patients with Helicobacter pylori infection. Lancet 1996, 347:1630-1631. This paper described a phase I clinical trial in which the safety of the antigen preparation (recombinant urease) was tested in patients who already had H. pylori disease. Urease was well tolerated by the patients, suggesting that this antigen represents a good candidate for a first generation vaccine.
16. Odenbreit S, Till M, Haas R: Identification of a Helicobacter pylori specific protein involved in adherence to gastric epithelial cells [Abstract]. Gut 1995, 37:A1.
17. Hanley S, Mullany P, Allan E, Tabaqchali S: Identification of genes encoding exported protein sequences in Helicobacter pylori using alkaline phosphatase vectors [Abstract]. Gut 1995, 37:A22.
18. Keenan J, Allardyce RA, Bagshaw P: Helicobacter felis surface antigens serve as protective targets in orally immunised mice [Abstract]. Gut 1995, 37:A93.
19. Engstrand L: Potential animal models of Helicobacter pylori infection in immunological and vaccine research. FEMS Immun Med Microbiol 1995, 10:265-270.
20. McColm AA, Bagshaw JA, O'Malley CO, McLaren A: Development of a mouse model of gastric colonisation with Helicobacter pylori [Abstract]. Gut 1995, 37:A50.
21. Glauser MH, Michetti P, Blum AL, Corthésy-Theulaz I: Carbon 14-urea breath test as a non-invasive method to monitor Helicobacter felis colonization in mice. Digestion 1996, 57:30-34.
22. Batchelder M, Fox JG, Monath T, Yan L, Attardo L, Georakopoulos K, Li X, Marini R, Shen Z, Pappo J, Lee C: Oral vaccination with recombinant urease reduces gastric Helicobacter pylori colonization in the cat [Abstract]. Gastroenterology 1996, 110:A58.
23. Mohammadi M, Czinn S, Nedrud J: Oral immunization prevents Helicobacter felis colonization of conventional mice but does not prevent inflammation [Abstract]. Gastroenterol 1994, 89:1343.
24. Pappo J, Thomas WD, Kabok Z, Taylor NS, Murphy NS, Fox JG: Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis. Infect Immun 1995, 63:1246-1252.
25. Claeys D, Corthésy-Theulaz I, Gaudin M, Saraga E, Porta N, Kraehenbuhl JP, Blum AL, Michetti P: Absence of H,K-ATPase serum autoantibodies in mice immunized against Helicobacter infection [Abstract]. Gastroenterology 1995, 108:A797.
26. Pizza M, Fontana MR, Giuliani MM, Domenighini M, Magagnoli C, Giannelli V, Nucci D, Hol W, Manetti R, Rappuoli R: A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit. J Exp Med 1994, 180:2147-2153.
27. Ghiara P, Marchetti M, Di Tommaso A, Saletti G, Burroni D, Figura N, Manetti R, Massari M, Marchini A, Arico B et al.: Infection by Helicobacter pylori in a mouse model that mimics human disease: protection by oral vaccination [Abstract]. Gut 1995, 37:A51.
28. Corthésy-Theulaz I, Corthésy B, Bachmann D, Porta N, Vaney AC, Saraga E, Michetti P, Kraehenbuhl J-P, Blum AL: Naked DNA immunization against Helicobacter infection [Abstract]. Gastroenterology 1996, 110:A889.
29. Mohammadi M, Nedrud J, Czinn S: Spleen cell proliferation after infection of immunization of conventional mice with Helicobacter felis [Abstract]. Am J Gastroenterol 1994, 89:1343.
30. Thomas JE, Austin S, Dale A, McClean P, Harding M, Coward WA, Weaver LT: Protection by human milk IgA against Helicobacter pylori infection in infancy. Lancet 1993, 342:121
31. Blanchard TG, Czinn SJ, Maurer R, Thomas WD, Soman G, Nedrud JG: Urease-specific monoclonal antibodies prevent Helicobacter felis infection in mice. Infect Immun 1995, 63:1394-1399. In this study, incubation of an H. felis inoculum with monoclonal antibodies directed against H. felis antigens appeared to neutralize the ability of the bacteria to colonize mice. Several of the antibodies were shown to recognize epitopes of H. felis urease. Monoclonal antibodies of both IgA and IgG classes were able to neutralize H. felis bacteria.
32. Rehnberg-Laiho L, Marnila P, Kosunen TU, Syvaoja E-L, Hanninen M-L, Karkkainen P, Rautelin H, Virtanen S, Lilus E-M, Korhonen H: Specific immune colostrum in the prevention of Helicobacter infection in mice [Abstract]. Gut 1995, 37:A92.
33. Korhonen H, Syvaoja EL, Aholaluttila H, Sivela S, Kopola S, Husu J: Bactericidal effect of bovine normal and immune serum, colostrum and milk against Helicobacter pylori. J Appl Bacteriol 1995, 78:655-662.